United States Pharmacovigilence Retapamulin-Prescribing

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT01153880
First received: June 29, 2010
Last updated: April 26, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2012
  Estimated Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)